» Articles » PMID: 22721647

Activated B Cells in the Granulomas of Nonhuman Primates Infected with Mycobacterium Tuberculosis

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2012 Jun 23
PMID 22721647
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

In an attempt to contain Mycobacterium tuberculosis, host immune cells form a granuloma as a physical and immunological barrier. To date, the contribution of humoral immunity, including antibodies and specific functions of B cells, to M. tuberculosis infection in humans remains largely unknown. Recent studies in mice show that humoral immunity can alter M. tuberculosis infection outcomes. M. tuberculosis infection in cynomolgus macaques recapitulates essentially all aspects of human tuberculosis. As a first step toward understanding the importance of humoral immunity to control of M. tuberculosis infection in primates, we characterized the B-cell and plasma-cell populations in infected animals and found that B cells are present primarily in clusters within the granuloma. The B-cell clusters are in close proximity to peripheral node addressin-positive cells and contain cells positive for Ki-67, a proliferation marker. Granuloma B cells also express CXCR5 and have elevated HLA-DR expression. Tissues containing M. tuberculosis bacilli had higher levels of M. tuberculosis-specific IgG, compared with uninvolved tissue from the same monkeys. Plasma cells detected within the granuloma produced mycobacteria-specific antibodies. Together, these data demonstrate that B cells are present and actively secreting antibodies specific for M. tuberculosis antigens at the site of infection, including lung granulomas and thoracic lymph nodes. These antibodies likely have the capacity to modulate local control of infection in tissues.

Citing Articles

Editorial: Tuberculosis and humoral immunity.

Dutt T, Choreno-Parra J Front Immunol. 2025; 16:1562567.

PMID: 39995662 PMC: 11847867. DOI: 10.3389/fimmu.2025.1562567.


Building Spatiotemporal Understanding of -Host Interactions.

Lawrence A, Tan S ACS Infect Dis. 2025; 11(2):277-286.

PMID: 39847659 PMC: 11828672. DOI: 10.1021/acsinfecdis.4c00840.


Immune correlates of protection as a game changer in tuberculosis vaccine development.

Wang J, Fan X, Hu Z NPJ Vaccines. 2024; 9(1):208.

PMID: 39478007 PMC: 11526030. DOI: 10.1038/s41541-024-01004-w.


Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development.

Chugh S, Bahal R, Dhiman R, Singh R NPJ Vaccines. 2024; 9(1):57.

PMID: 38461350 PMC: 10924964. DOI: 10.1038/s41541-024-00834-y.


Comparison of the Single Cell Immune Landscape between Subjects with High Bacillary Loads during Active Pulmonary Tuberculosis and Household Members with Latent Tuberculosis Infection.

Kamolratanakul S, Ariyanon W, Udompornpitak K, Bhunyakarnjanarat T, Leelahavanichkul A, Dhitavat J Cells. 2024; 13(4.

PMID: 38391975 PMC: 10887672. DOI: 10.3390/cells13040362.


References
1.
Zhang S, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, Puel A . Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol Rev. 2009; 226:29-40. DOI: 10.1111/j.1600-065X.2008.00698.x. View

2.
Halstead S, Mahalingam S, Marovich M, Ubol S, Mosser D . Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis. 2010; 10(10):712-22. PMC: 3057165. DOI: 10.1016/S1473-3099(10)70166-3. View

3.
Kleindienst P, Brocker T . Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo. Immunology. 2005; 115(4):556-64. PMC: 1782172. DOI: 10.1111/j.1365-2567.2005.02196.x. View

4.
C Willcocks L, Smith K, Clatworthy M . Low-affinity Fcgamma receptors, autoimmunity and infection. Expert Rev Mol Med. 2009; 11:e24. DOI: 10.1017/S1462399409001161. View

5.
Khan I, Ravindran R, Krishnan V, Awan I, Rizvi S, Saqib M . Plasma antibody profiles as diagnostic biomarkers for tuberculosis. Clin Vaccine Immunol. 2011; 18(12):2148-53. PMC: 3232686. DOI: 10.1128/CVI.05304-11. View